Compound Profiles
CJC-1295 (without DAC)
Short-Acting Growth Hormone Releasing Hormone Analog
Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.
MOTS-c
Mitochondrial-Derived Peptide | Metabolic Regulator
Inhibits the folate cycle leading to AMPK activation. Under metabolic stress, translocates to nucleus to bind stress-response transcription factors, regulating genes involved in metabolism, insulin sensitivity, and cellular adaptation.
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take CJC-1295 (without DAC) with MOTS-c?
Yes, CJC-1295 (without DAC) and MOTS-c can generally be taken together. CJC-1295 (without DAC) helps counteract the insulin-disrupting effects of MOTS-c. A smart combination — the insulin sensitizer mitigates metabolic side effects.
Is CJC-1295 (without DAC) and MOTS-c safe together?
Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: insulin disrupting, teratogenic. Monitor accordingly.
What are the interactions between CJC-1295 (without DAC) and MOTS-c?
CJC-1295 (without DAC) helps counteract the insulin-disrupting effects of MOTS-c. A smart combination — the insulin sensitizer mitigates metabolic side effects. This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.
How should I time CJC-1295 (without DAC) and MOTS-c?
CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours and MOTS-c has a half-life of ~30 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.